Cornea/External Disease News

OCT imaging captured significantly greater meibomian gland length than traditional meibography, likely due to a longer wavelength that penetrates deeper into the eyelids, according to a study published in Contact Lens and Anterior Eye.

BOSTON — In this Healio Video Perspective from the ASCRS meeting, Eris Jordan, OD, of Aurion Biotech, and Elizabeth Yeu, MD, FACS, discuss corneal endothelial cell therapy.

Provectus Biopharmaceuticals announced an exclusive worldwide license agreement with the University of Miami for the university’s photodynamic antimicrobial therapy to treat bacterial, fungal and parasitic eye infections.

BOSTON — In this Healio Video Perspective from the ASCRS meeting, Eric D. Donnenfeld, MD, discusses his presentation on Lacrifill for the treatment of dry eye disease.

BOSTON — In this Healio Video Perspective from the ASCRS meeting, Brandon D. Ayres, MD, ABO, overviews surgical techniques that offer an alternative to corneal transplantation for the treatment of keratoconus.

BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Nordic Pharma Eye Care U.S. president Philip Gioia and chief commercial officer Jai G. Parekh, MD, MBA, FAAO, discuss the launch of Lacrifill for dry eye disease.

BOSTON — In this Healio Video Perspective from the ASCRS meeting, Michael B. Raizman, MD, ABO, discusses the future of corneal cross-linking.

BOSTON — Annual exams with topography are key to identifying progression in patients with keratoconus regardless of whether they have undergone cross-linking, according to a speaker here.

BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Greg Kunst, CEO of Aurion Biotech, discusses the company’s cell therapy for corneal endothelial disease.

NEW YORK — Topography-guided PRK and CTAK can change the corneal curvature in patients with keratoconus, according to a speaker at Vision Expo East.